Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Li X et al. | 2020 | mouse/BALB/c (nude mice) | magnetic field, low frequency, 50/60 Hz | - |
| Dong Y et al. | 2021 | intact cell/cell culture | magnetic field, signals/pulses, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Takahashi M et al. | 2022 | intact cell/cell culture, human induced pluripotent stem cells | magnetic field, 50/60 Hz | - |
| Haroutunian GG et al. | 2022 | intact cell/cell culture, human adipose tissue‐derived mesenchymal stem progenitor cells (MSPCs) | magnetic field, intermediate frequency, 50/60 Hz | - |
| Costantini E et al. | 2022 | - | magnetic field, low frequency, 50/60 Hz | - |
| Huang L et al. | 2022 | intact cell/cell culture, mouse bone marrow-derived mesenchymal stem cells, animal, C57BL/6 mouse | magnetic field, signals/pulses, 50/60 Hz | - |
| Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
| Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
| Caliogna L et al. | 2022 | intact cell/cell culture, human adipose-derived mesenchymal stem cells and primary human osteoblasts | magnetic field, signals/pulses, 50/60 Hz, therapeutic/medical device | - |
| Lee YJ et al. | 2015 | intact cell/cell culture, human bone marrow-derived mesenchymal stem cells (hBM-MSCs) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
